MIC AND MBC IN THE EVALUATION OF THE CLINICAL RELEVANCE OF BETA-LACTAMS PRODUCED IN LUBUMBASHI IN THE DR OF CONGO
Global Health Synapse · 31.10.2025 · 2 (1) · 1-9
DOI: 10.63456/ghs-2-1-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Health Synapse, online erschienen am 31.10.2025. Verfasst von Kasamba Ilunga Éric und 2 weiteren Autor:innen. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Faced with the recurring problems of bacterial resistance to antibiotics and the ineffectiveness of medical therapies used to cure patients with bacterial infections, it is urgent not only to think about the development of new therapeutic strategies to guarantee the future, but above all, for the present to set up mechanisms allowing a judicious selection of antibiotics according to various parameters, in particular microbiological: The minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC). Methodology The determination of the MIC and MBC was carried out according to the recommendations of the Clinical & Laboratory Standards Institute (CLSI). The bacterial population consisted of strains typed Staphylococcus aureus (ATCC 25923) and Escherichia coli (ATCC 25922) conditioned under an adjusted turbidity of 0.5 McFarland. We used Mueller Hinton broth and Mueller Hinton agar for MIC and determination of inhibition diameters and trypcase soy agar for subculture of the MBC determination. And a MBC/MIC ratio was calculated for determination of the potency of antibiotics.
Results
After determination of the MIC and MBC values, calculation of the MBC/MIC ratio, it appears that only Meropenem has a bactericidal action on the two ATCC bacteria and for the antibiotics produced by the two firms; Ceftriaxone demonstrated a bactericidal action on Staphylococcus aureus for both firms. For the rest, the antibiotics demonstrated essentially bacteriostatic activity for both bacteria and for both firms.
Conclusion
In this study, their measurement allowed to evaluate the quality of some antibiotics manufactured by two local firms by specifying the power of their activity on the reference strains. These results and practices are recommended in the daily practice of microbiology laboratories as an element of quality control of the routine antibiogram technique. This practice can be extended to the search for MIC and CMB on the serum of patients in order to ensure the good crossing by the antibiotic of the different biological barriers and thus guarantee the effectiveness of the treatment, particularly in intensive care units.
Zitieren
APA
Éric, K. I., Charles, K. K., & Tshikolasoni, H. (2025). MIC AND MBC IN THE EVALUATION OF THE CLINICAL RELEVANCE OF BETA-LACTAMS PRODUCED IN LUBUMBASHI IN THE DR OF CONGO. Global Health Synapse, 2(1), 1-9. https://doi.org/10.63456/ghs-2-1-9
Vancouver
Éric KI, Charles KK, Tshikolasoni H. MIC AND MBC IN THE EVALUATION OF THE CLINICAL RELEVANCE OF BETA-LACTAMS PRODUCED IN LUBUMBASHI IN THE DR OF CONGO. Global Health Synapse. 2025;2(1):1-9. doi:10.63456/ghs-2-1-9
BibTeX
@article{ric2025,
author = {Éric, Kasamba Ilunga and Charles, Kimuni Kamona and Tshikolasoni, Hichika},
title = {MIC AND MBC IN THE EVALUATION OF THE CLINICAL RELEVANCE OF BETA-LACTAMS PRODUCED IN LUBUMBASHI IN THE DR OF CONGO},
journal = {Global Health Synapse},
year = {2025},
volume = {2},
number = {1},
pages = {1--9},
doi = {10.63456/ghs-2-1-9}
}
EUVIMED